Welcome!
Maybank Kim Eng
Broker's Calls
More analysts start coverage on Aztech Global with optimistic ratings
More analysts have given optimistic ratings on Aztech Global after its strong profit showing.
April 26, 2021
Broker's Calls
Analysts mostly upbeat on A-REIT as 1Q21 shows positive rental reversion
Maybank Kim Eng, CGS-CIMB, OCBC and UOB Kay Hian kept their 'buy' or 'add' calls for A-REIT.
April 26, 2021
Broker's Calls
Analysts divided on Keppel REIT’s 1QFY2021 business update
CGS-CIMB and Maybank retained their 'buy' and 'sell' ratings respectively for Keppel REIT.
April 22, 2021
Broker's Calls
Deferment of BeerCo IPO may be opportunity to accumulate ThaiBev stocks: Maybank Kim Eng
To Maybank's Chan, the deferment of BeerCo’s IPO is more likely due to a lower-than-expected valuation for the business.
April 21, 2021
Broker's Calls
'Buy' CDG as technical indicators show a new upcycle about to unfold: Maybank KE
Maybank Kim Eng believes a new upcycle is about to unfold to the next resistance at $1.81, then $1.99.
April 05, 2021
Broker's Calls
Maybank Kim Eng initiates coverage on Q&M Dental with 'buy' call and TP of 87 cents
Maybank Kim Eng expects Q&M's earnings to be underpinned by growth from its Covid-19 testing business and more clinics.
April 01, 2021
Broker's Calls
Continue to 'hold' SPH REIT as 1H21 results fall in line with expectations: analysts
Analysts from Maybank Kim Eng and OCBC retained their ‘hold’ ratings for SPH with unchanged target prices.
April 01, 2021
Broker's Calls
More restructurings and privatisations to come, says Maybank Kim Eng
Possible candidates for restructuring include Singtel, Frasers Property, UOL and ThaiBev.
March 29, 2021
Broker's Calls
Analysts mixed on Singapore technology sector, RHB downgrades rating to ‘neutral’
RHB Group Research and Maybank Kim Eng give their takes on the Singapore tech sector.
March 16, 2021
Broker's Calls
Analysts mixed on First Resources following FY20 results, RHB downgrades rating to 'neutral'
The company's forward sales transactions have analysts divided on its FY21 outlook.
March 04, 2021